Meta‐analysis made by Fang et al. using total DNA from peripheral blood and tumor, suggests a strong association between the RARB2 methylated promoter (Fang, Jian, et al., 2015) and GSTP1 methylated promoter and breast cancer (Fang, Wei, et al., 2015). Here, GSTP1 is linked to breast carcinoma.